T2 Biosystems to Host Business Update Call on October 10, 2024

Rhea-AI Summary

T2 Biosystems, a leader in rapid sepsis pathogen and antibiotic resistance gene detection, has announced a business update call scheduled for October 10, 2024, at 4:30pm ET. The call will provide additional details on recent developments and address select shareholder questions submitted in advance to ir@T2Biosystems.com.

Investors can access the call through:

• A live and archived webcast at www.t2biosystems.com (Investors page, Events & Presentations section)
• Dialing 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International) with passcode 702677

Participants are advised to dial in approximately ten to five minutes before the start time.

LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a business update call to provide additional details on recent developments after market close at 4:30pm ET on Thursday October 10, 2024. On the call management also plans to address select questions from shareholders that can be submitted in advance to the investor relations team at ir@T2Biosystems.com.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 702677, approximately ten to five minutes prior to the start time.

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products are powered by the proprietary T2 Magnetic Resonance (T2MR^®) technology and include the T2Dx^® Instrument, the T2Bacteria^® Panel, the T2Candida^® Panel, the T2Resistance^® Panel, and the T2Biothreat™ Panel. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the T2Lyme™ Panel, and the expended T2Candida Panel to add the detection of Candida auris. For more information, please visit www.t2biosystems.com.

Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406

FAQ

When is T2 Biosystems (TTOO) hosting its business update call?

T2 Biosystems (TTOO) is hosting its business update call on Thursday, October 10, 2024, after market close at 4:30pm ET.

How can investors listen to T2 Biosystems' (TTOO) business update call?

Investors can listen to T2 Biosystems' (TTOO) business update call via a live webcast at www.t2biosystems.com or by dialing 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International) with passcode 702677.

What topics will T2 Biosystems (TTOO) cover in its October 10, 2024 business update call?

T2 Biosystems (TTOO) will provide additional details on recent developments and address select shareholder questions during its October 10, 2024 business update call.

How can shareholders submit questions for T2 Biosystems' (TTOO) business update call?

Shareholders can submit questions in advance for T2 Biosystems' (TTOO) business update call by emailing the investor relations team at ir@T2Biosystems.com.